Lobbying Relationship

Client

Acceleron Pharma, Inc

More records

Lobbying firm

SPLITOAK STRATEGIES LLC

More records

  • HR 5376, Build Back Better Act-impact on rare disease research
  • HR 5376, Build Back Better Act-importance of the Orphan Drug Tax Credit for rare diseases

Duration: to

General Issues: Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Pharmacy

Spending: about $90,000 (But it's complicated. Here's why.)

Agencies lobbied since 2021: House of Representatives, U.S. Senate

Bills mentioned

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.5376: Inflation Reduction Act of 2022

Sponsor: John Yarmuth (D-Ky.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Amy Jensen Cunniffe Special Assistant to the President for Legislative Affairs; Assistant to the Speaker Of the House for Policy; Legislative Assistant; Policy Analyst Special Assistant to the President for Legislative Affairs (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999) Special Assistant to the President (2003-2005); Assistant to the Speaker for Policy (1999-2001); Policy Analyst, Office of the Majority Whip (1995-1999)
Sarah Egge 1998-2000, Legislative Assistant, Senator Bob Kerrey; 2001-2012 Senior Budget Analyst, Democratic Staff, Senate Budget Committee; Fall 2011, Deputy Staff Director, Joint Select Committee on Deficit Reduction Legislative Assistant, Sen. Bob Kerrey (1998-2000); Senior Budget Analyst, Senate Budget Committee (2001-2012); Deputy Staff Director, Joint Select Committee on Deficit Reduction (Fall 2011)

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q4 Report
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page